Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
CHIMERIX INC (CMRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/19/2021 |
8-K/A
| Other Events, Financial Statements and Exhibits Interactive Data|
Docs:
|
"Consent of Cohn Reznick LLP, independent registered public accounting firm",
"Audited financial statements of Oncoceutics as of and for the years ended December 31, 2019 and 2018, together with the notes thereto and the auditors' report thereon",
"Unaudited interim financial statements of Oncoceutics as of September 30, 2020 and for the nine months ended September 30, 2020 and 2019",
"Unaudited pro forma consolidated combined balance sheet for the Company and Oncoceutics as of September 30, 2020 and unaudited pro forma consolidated combined statements of operations for the Company and Oncoceutics for the year ended December 31, 2019 and for the nine months ended September 30, 2020" |
|
|
|